These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9038691)

  • 1. Impaired left ventricular filling dynamics in patients with angina and angiographically normal coronary arteries: effect of beta adrenergic blockade.
    Fragasso G; Chierchia SL; Pizzetti G; Rossetti E; Carlino M; Gerosa S; Carandente O; Fedele A; Cattaneo N
    Heart; 1997 Jan; 77(1):32-9. PubMed ID: 9038691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of trimetazidine with atenolol in patients with syndrome X: effects on diastolic function and exercise tolerance.
    Leonardo F; Fragasso G; Rossetti E; Dabrowski P; Pagnotta P; Rosano GM; Chierchia SL
    Cardiologia; 1999 Dec; 44(12):1065-9. PubMed ID: 10687257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance contrast enhancement with gadolinium-DTPA in patients with angina and angiographically normal coronary arteries: effect of chronic beta-blockade.
    Rossetti E; Fragasso G; Mellone R; Vanzulli A; Del Maschio A; Chierchia SL
    Cardiologia; 1999 Jul; 44(7):653-9. PubMed ID: 10476591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of beta-adrenergic blockade on left ventricular relaxation and filling dynamics in coronary artery disease: a pulsed Doppler echocardiographic study.
    Myreng Y; Ihlen H; Nitter-Hauge S
    Eur Heart J; 1988 Nov; 9(11):1167-74. PubMed ID: 2906870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the exercise treadmill test and 24-hour ECG Holter monitoring in patients with syndrome X or coronary atherosclerosis.
    Guzik P; Rogacka D; Trachalski J; Minczykowski A; Baliński M; Wykretowicz A; Wysocki H
    Kardiol Pol; 2007 Mar; 65(3):262-9; discussion 270-1. PubMed ID: 17436154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of left ventricular filling in coronary artery disease and myocardial ischaemia after dipyridamole provocation.
    Shahi M; Nadazdin A; Foale RA
    Br Heart J; 1991 May; 65(5):265-70. PubMed ID: 2039671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal myocardial glucose handling in patients with syndrome X: effect of beta-adrenergic blockade.
    Fragasso G; Chierchia SL; Rossetti E; Landoni C; Lucignani G; Fazio F
    G Ital Cardiol; 1997 Nov; 27(11):1113-20. PubMed ID: 9419821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of selective beta-adrenergic blockade on insulin sensitivity and release in control subjects and in patients with angina and normal coronary arteries (syndrome X).
    Fragasso G; Cattaneo N; Locatelli M; Caumo A; Pagnotta P; Piatti P; Bonini P; Chierchia SL
    G Ital Cardiol; 1998 Jun; 28(6):623-9. PubMed ID: 9672774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of angiotensin-converting enzyme inhibition on exercise-induced angina and ST segment depression in patients with microvascular angina.
    Kaski JC; Rosano G; Gavrielides S; Chen L
    J Am Coll Cardiol; 1994 Mar; 23(3):652-7. PubMed ID: 8113548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical treatment of patients with severe exertional and rest angina: double blind comparison of beta blocker, calcium antagonist, and nitrate.
    Quyyumi AA; Crake T; Wright CM; Mockus LJ; Fox KM
    Br Heart J; 1987 Jun; 57(6):505-11. PubMed ID: 3304367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of oral aminophylline in patients with angina and normal coronary arteriograms (cardiac syndrome X).
    Elliott PM; Krzyzowska-Dickinson K; Calvino R; Hann C; Kaski JC
    Heart; 1997 Jun; 77(6):523-6. PubMed ID: 9227295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different effects of calcium antagonist and beta-blocker therapy on left-ventricular diastolic function in ischemic heart disease. A direct comparison of the impact of mibefradil and atenolol.
    Hassager C; Thygesen K; Grande P; Fischer Hansen J; Mickley H; Gustafsson I; Skagen K; Steensgaard-Hansen F
    Cardiology; 2001; 96(2):65-71. PubMed ID: 11740134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of doxazosin on exercise-induced angina pectoris, ST-segment depression, and insulin sensitivity in patients with syndrome X.
    Bøtker HE; Sonne HS; Schmitz O; Nielsen TT
    Am J Cardiol; 1998 Dec; 82(11):1352-6. PubMed ID: 9856918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Celiprolol and atenolol in angina--effects on left ventricular function.
    Dargie H; McLenachan JM; Wilson JT
    J Int Med Res; 1988; 16 Suppl 1():47A-51A. PubMed ID: 2906017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary microvascular spasm triggers transient ischemic left ventricular diastolic abnormalities in patients with chest pain and angiographically normal coronary arteries.
    Arrebola-Moreno AL; Arrebola JP; Moral-Ruiz A; Ramirez-Hernandez JA; Melgares-Moreno R; Kaski JC
    Atherosclerosis; 2014 Sep; 236(1):207-14. PubMed ID: 25075937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue velocity echocardiography shows early improvement in diastolic function with irbesartan and atenolol therapy in patients with hypertensive left ventricular hypertrophy. Results form the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA).
    Müller-Brunotte R; Kahan T; Malmqvist K; Ring M; Edner M
    Am J Hypertens; 2006 Sep; 19(9):927-36. PubMed ID: 16942935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular function in mild hypertension after adrenergic blockade.
    Dianzumba SB; DiPette D; Joyner CR; Townsend R; Weber E; Mauro K; Cornman C
    Hypertension; 1988 Feb; 11(2 Pt 2):I98-102. PubMed ID: 3346069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary microvascular function and cortical pain processing in patients with silent positive exercise testing and normal coronary arteries.
    Di Franco A; Lanza GA; Di Monaco A; Sestito A; Lamendola P; Nerla R; Tarzia P; Virdis D; Vollono C; Valeriani M; Crea F
    Am J Cardiol; 2012 Jun; 109(12):1705-10. PubMed ID: 22459303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of diltiazem on coronary flow reserve in patients with microvascular angina.
    Sütsch G; Oechslin E; Mayer I; Hess OM
    Int J Cardiol; 1995 Nov; 52(2):135-43. PubMed ID: 8749873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.